The company expects to provide details on the financial impact of the acquisition on the third quarter financial report. “The addition of the MicroFrance business advances our strategic objectives by enhancing our existing instruments portfolio and capabilities, expanding our international presence and providing potential adjacency opportunities in the neurosurgery business,” said Integra CFO Glenn Coleman.
The company reported in September that executives are looking past the spine business to grow in the future. Integra’s second quarter total revenue increased 12.6 percent over the same period last year, with 45 percent growth in neurosurgery, but only 4 percent growth in the United States spine business.
At the time, CEO Peter Arduini said the company prefers to focus on “organically running the business” instead of acquiring other companies.
More articles on spine devices:
Stryker, Medtronic, Aurora Spine & more—11 key notes
Aurora Spine, Sentio sign distribution agreement for nerve mapping system
X-spine Systems adds biologics line to portfolio
